|
|
The behavior study on the increase of susceptibility to epilepsy in Wistar rats by β-amyloid protein |
ZHAO Juan1 ZHANG Yanmei2 ZHENG Naizhi1 |
1.Department of Neurology, Qingdao Municipal Hospital Affiliated to Qingdao University, Shandong Province, Qingdao 266011, China;
2.Department of Primay Medical Management, Qingdao Municipal Hospital Affiliated to Qingdao University, Shandong Province, Qingdao 266011, China |
|
|
Abstract Objective To study the effects of β-amyloid protein (Aβ) on the pathogenesis of epilepsy (EP). Methods 40 male Wistar rats were divided into Aβ1-42 + PILO group, Aβ1-42 group, PBS + PILO group and PBS group by random number table, with 10 rats in each group. The former two groups were called Aβ1-42 model group and the later PBS control group. Aβ1-42 and same volume PBS were injected into the hippocampal CA3 region of Wistar rats in Aβ1-42 model group and PBS control group by stereotaxic apparatus respectively, and the Morris water maze test was observed after 2 weeks. Escape latency, the percentage of swimming time in the target quadrant and the number of times of crossing the platform were recorded. After the AD model was successfully made, the rat model of chronic EP was established by intraperitoneal injection of LI-PILO. The latency of EP, degree of seizure and mortality of rats were recorded according to Racine grading criteria. Results One rat died in Aβ1-42 model group and the PBS control group. The results of Morris water maze test showed that compared with the PBS control group, the escape latency of the Aβ1-42 model group was longer (P < 0.01), the proportion of swimming time in the target quadrant was shorter (P < 0.05), and the number of crossing the platform was also significantly reduced (P < 0.05). It indicated that the AD model was successfully prepared. Preparation of rats EP model: The latency of EP in Aβ1-42 + PILO group was significantly shorter (P < 0.01), and the degree of seizure was more severe (P < 0.05), compared with PBS + PILO group, according to Racine grading criteria. The mortality of rats in Aβ1-42 + PILO group was significantly increased compared with PBS + PILO group (P < 0.05). Conclusion It can lead to the impaired hippocampus-related learning and memory function by injection of Aβ1-42 in hippocampal CA3 region of rats. The existing of Aβ increasing the susceptibility to EP in the rats, which indicates that Aβ plays a facilitation role in the occurrence of EP.
|
|
|
|
|
[1] Brooks-Kayal AR,Bath KG,Berg AT,et al. Issues related to symptomatic and diseaase-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy [J]. Epilepsia,2013,54(4):44-60.
[2] Bae EK,Jung KH,Chu K,et al. Neuropathologic and clinical features of human medial temporal lobe epilepsy [J]. J Clin Neurol,2010,6(2):73-80.
[3] Sillanpaa M,Gissler M,Schmidt D. Efforts in epilepsy prevention in the last 40 years:lessons from a large nation wide study [J]. JAMA Neurol,2016,73(4):390-395.
[4] Quan Q,Wang J,Li X,et al. Ginsenoside Rg1 decreases Abeta(1-42)level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer′s disease [J]. PLoS One,2013,8(3):e591-595.
[5] Jia S,Lu Z,Gao Z,et al. Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-beta1-42-induced rat model of Alzheimer′s disease [J]. Int J Biol Macromol,2016, 83:416-425.
[6] Fang Z, Chen S,Qin J,et al. Pluronic P85- coated poly(butylcyanoacrylate)nanoparticles overcome phenytoinresistance in P-glycoprotein overexpressing rats with lithium- pilocarpine-inducedchronic temporal lobe epilepsy [J]. Biomaterials,2016,97:110-121.
[7] Racine RJ. Modification of seizure activity by electrical stimulation.Ⅱ. Motor seizure,Electroencephalogr [J]. Electroencephalogr Clin Neurophysiol,1972,32(3):281-294.
[8] Tuchman R,Alessandri M,Cuccaro M. Autism spectrum disorders and epilepsy:moving towards a comprehensive approach to treatment [J]. Brain Dev,2010,32(9):719-730.
[9] Jonsson T,Atwal JK,Steinberg S,et al. A mutation in APP protects against Alzheimer disease and age-related cognitive deline [J]. Nature,2012,488(7409):96-99.
[10] Enache TA,Oliveira-Brett AM. Alzheimer′s disease amyloid beta peptides in vitro electrochemical oxidation [J]. Bioelectrochemistry,2016,114:13-23.
[11] Lahmy V,Meunier J,Malmstrom S,et al. Blockade of Tau hyperphosphorylation and Aβ1-42 generation by the aminotetrahydrofuran derivative ANAVEX2-73,a mixed muscarinic and σ1 receptor agonist,in a nontransgenic mouse model of Alzheimer′s disease [J]. Neuropsychopharmacology,2013,38(9):1706-1723.
[12] 刘阳,韩春雷,孟凡刚.匹罗卡品癫痫模型研究进展[J].中华神经外科杂志,2014,30(1):88-90.
[13] Born HA,Kim JY,Savjani RR,et al. Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzeimer′s disease [J]. J Neurosci,2014,34(11):3826-3840.
[14] Roberson ED,Halabisky B,Yoo JW,et al. Amyloid-beta/Fyn-induced synaptic,network,and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease [J]. J Neurosci,2011,31(2):700-711.
[15] Chandra V,Bharucha NE,Schoenberg BS. Conditions associated with Alzheimer disease at death:case–control study [J]. Neurology,1986,36(2):209–211.
[16] Corcoran KA,Lu Y,Turner RS,et al. Over expression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer disease [J]. Learn Mem,2002,9(5):243–252.
[17] Palop JJ,Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease [J]. Nat Rev Neurosci.2016,17(12):777-792.
[18] Palop JJ,Chin J,Roberson ED,et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer′s disease [J]. Neuron,2007,55(5):697-711.
[19] Scarmeas N,Honig LS,Choi H. Seizure in Alzheimer disease:who,when,and how common?[J] Arch Network,2009,66(8):435-440.
[20] Luscher C,Malenka RC. Drug-evoked synaptic plasticity in addiction:from molecular changes to circuit remodeling [J]. Neuron,2011,69(4):650-663. |
|
|
|